Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers
Condition:   Healthy Volunteers Interventions:   Drug: AZD9833;   Drug: Midazolam;   Drug: Omeprazole;   Drug: Dabigatran Etexilate;   Drug: Celecoxib Sponsor:   AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2022 Category: Research Source Type: clinical trials

Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Conditions:   Cushing Syndrome;   Neoplasms Interventions:   Drug: Dabigatran Etexilate;   Drug: Relacorilant Sponsor:   Corcept Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2022 Category: Research Source Type: clinical trials